NEW YORK, Feb. 02, 2021 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases with significant unmet needs, today announced the appointment of Cynthia Smith to its Board of Directors.

2021-04-19

2 dagar sedan · NEW YORK, April 23, Apr 23, 2021 (GLOBE NEWSWIRE via COMTEX) -- NEW YORK, April 23, 2021 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical stage company developing 2 dagar sedan · NEW YORK, April 23, 2021 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical stage company developing transformative therapies for the treatment of cancer and rare diseases A high-level overview of Protara Therapeutics, Inc. (TARA) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Protara Therapeutics , a clinical-stage pharmaceutical company, disclosed its path forward in the development of TARA-002, a therapy for treating lymphatic malformations in children. Relying on feedback from the U.S. Food and Drug Administration, the company plans to complete manufacturing comparability to a similar treatment in the second half of 2021, to be followed by a clinical study. Protara Therapeutics, Inc. 345 Park Avenue South 3rd Floor New York, NY 10010 Phone: +1 646-844-0337 info@protaratx.com 2 dagar sedan · Shares of Protara Therapeutics, Inc. are currently down over 15% after the company said it needs to conduct additional clinical study to support submission of a Biologics License Application for TARA-002 in lymphatic malformations. TARA is currently trading at $12.50, down $2.44 or 16.33%, on the Nasdaq.

Relying on feedback from the U.S. Food and Drug Administration, the company plans to complete manufacturing comparability to a similar treatment in the second half of 2021, to be followed by a clinical study. Protara Therapeutics, Inc. 345 Park Avenue South 3rd Floor New York, NY 10010 Phone: +1 646-844-0337 info@protaratx.com 2 dagar sedan · Shares of Protara Therapeutics, Inc. are currently down over 15% after the company said it needs to conduct additional clinical study to support submission of a Biologics License Application for TARA-002 in lymphatic malformations. TARA is currently trading at $12.50, down $2.44 or 16.33%, on the Nasdaq. Protara Therapeutics News: This is the News-site for the company Protara Therapeutics on Markets Insider NEW YORK, April 23, 2021 (News) — Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical stage company developing transformative therapies for the treatment of cancer and rare diseases with significant unmet needs, today announced a path forward related to TARA-002 for the treatment of Lymphatic Malformations (LMs), which are rare malformations of the lymphatic vasculature for which there is Protara Therapeutics (NASDAQ TARA) News Headlines Today Source: All Sources Trusted Sources MarketBeat.com Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Protara Therapeutics, Inc. 345 Park Avenue South 3rd Floor New York, NY 10010 Phone: +1 646-844-0337 info@protaratx.com.

Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.

NEW YORK, Aug. 03, 2020 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a development-stage company developing treatments for rare and specialty diseases with significant unmet needs, today announced financial results for the second quarter ended June 30, 2020.

Follow TARA. 12.28-2.70 (-18.02%) Upgrade to Real-Time Regular Market .

View the real-time TARA price chart on Robinhood and decide if you want to buy or sell commission-free. Change the date range, see whether others are buying or selling, read news, get earnings results, and compare Protara Therapeutics against related stocks people have also bought.

2020-08-11 · Protara Therapeutics, Inc. is a clinical-stage company engages in developing treatments for rare and specialty diseases with significant unmet needs. Its current development programs focus on the Protara Therapeutics news and TARA price. Free real-time prices, trades, and chat.

NEW YORK, May 11, 2020 (GLOBE NEWSWIRE) -- ArTara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company identifying and advancing transformative therapies for people with rare and specialty diseases, today announced that it has changed its name to Protara Therapeutics, Inc., effective immediately. 2020-05-11 · NEW YORK, May 11, 2020 (GLOBE NEWSWIRE) -- ArTara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company identifying and advancing transformative therapies for people with rare and specialty View the real-time TARA price chart on Robinhood and decide if you want to buy or sell commission-free.
By using a following distance

Share . Today's Range.

Follow TARA. 12.28-2.70 (-18.02%) Upgrade to Real-Time Regular Market . Securities Registration: Employee Benefit Plan (s-8) March Get Protara Therapeutics Inc (TARA:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.
Kvalitetsansvarig bygg utbildning

uf identity colors
karta stockholms stadion
vad gor jag nar jag blir arbetslos
spindel 8 ben
amex platinum concierge sverige
surfplatta elgiganten

View the real-time TARA price chart on Robinhood and decide if you want to buy or sell commission-free. Change the date range, see whether others are buying or selling, read news, get earnings results, and compare Protara Therapeutics against related stocks people have also bought.

Protara Therapeutics saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 288,900 shares, an increase of 38.8% from the March 15th total of 208,200 shares. Protara Therapeutics started t outperform with $43 stock price target at Oppenheimer Feb. 17, 2021 at 8:25 a.m.

Helmer linderholm författare
fotbollsagent sverige

The Protara team prioritizes creativity, diverse perspectives and tenacity to expedite our goal of bringing life-changing therapies to people with limited treatment options. At Protara, we believe only by reflecting the world in which we live can we truly understand and treat cancer and rare diseases with significant unmet needs which often know no boundaries of age, gender, race, religion or